GABRIELLE WEAVER: Open Payments
NPI 1881341394 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 78 payments from 19 companies in 2025. Trend: 2023 $390 · 2024 $1,388 · 2025 $1,965
Food & beverage: $1,786Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $436 |
| Galderma Laboratories, L.P. | 6 | $272 |
| Arcutis Biotherapeutics, Inc. | 5 | $177 |
| Novartis Pharmaceuticals Corporation | 17 | $177 |
| ABBVIE INC. | 9 | $173 |
| PFIZER INC. | 5 | $158 |
| Journey Medical Corporation | 2 | $110 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
| Regeneron Pharmaceuticals, Inc. | 1 | $68 |
Products named: TREMFYA, NEMLUVIO, Zoryve, DUPIXENT, SKYRIZI, LITFULO, COSENTYX, TALTZ.
Industry payments across IN — which companies pay providers there.
